Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
186 Cards in this Set
- Front
- Back
function of lymph node?
|
nonspecific filtration by macrophage
storage and activation of B and T cells antibody production |
|
function of follicle in lymph node
|
site of B cell localization and proliferation
in outer cortex, 1' follicle dense and dormant 2' follicles have pale central germinal centers and active |
|
function of medulla in lymph node
|
medullary cord - closely packed lymphocytes and plasma cells
medullary sinus - communicate w/ efferent lymphatics and contain reticular cells and macrophages |
|
function of paracortex in lymph node
|
houses T cells
high endothelial venules present enlarges in extreme cellular response |
|
to which lymph node do these parts drain?
upper limb, lateral breast |
axillary
|
|
to which lymph node do these parts drain?
stomach |
celiac
|
|
to which lymph node do these parts drain?
duodenum, jejunum |
superior mesenteric
|
|
to which lymph node do these parts drain?
sigmoid colon |
colic - inferior mesenteric
|
|
to which lymph node do these parts drain?
rectum (lower part), anal canal above pectinate line |
internal iliac
|
|
to which lymph node do these parts drain?
anal canal below pectinate line |
superficial inguinal
|
|
to which lymph node do these parts drain?
testes |
superficial and deep plexuses -> para aortic
|
|
to which lymph node do these parts drain?
scrotum |
superficial inguinal
|
|
to which lymph node do these parts drain?
thigh (superficial) |
superficial inguinal
|
|
to which lymph node do these parts drain?
lateral side of dorsum of foot |
popliteal
|
|
thoracic duct drains every lymph node in our body except?
|
right arm and right half of head (drain to right lymphatic duct)
|
|
what's a sinusoid of spleen?
|
long vascular channels in red pulp with fenestrated barrel hoop basement membrane. macrophages found nearby.
|
|
in what part of the spleen are T cells found ?
|
periarterial lymphatic sheath (PALS) and red pulp of the spleen
|
|
in what part of the spleen are B cells found?
|
follicles within the white pulp of the spleen
|
|
what do macrophages in the spleen remove?
|
encapsulated bacteria
|
|
what's the fxn of thymus?
|
site of T cell differentiation and maturation
|
|
where does the thymus arise from? (embryology)
|
epithelium of 3rd branchial pouch
|
|
what's in the cortex of thymus?
|
immature T cell
|
|
what's in the medulla of thymus?
|
mature T cell, epithelial reticular cells and contains Hassall's corpuscle
|
|
what is positive selection?
|
if T cell can hind to MHC, T cell survives. if not, T cell dies
|
|
what is negative selection?
|
eliminating T cells that are reactive to own antigens
|
|
where in the thymus do positive/negative selection occur?
|
positive - thymic cortex
negative - corticomedullary jxn |
|
what is innate immunity?
|
receptors that recognize pathogens are germline encoded.
fast and non specific. no memory neutrophil, macrophage, dendritic cell, complement |
|
what is adaptive immunity?
|
receptors that recognize pathogens undergo VDJ recombination during lymphocyte development.
response is slow on first exposure, but memory response is faster and more robust. T cell, B cell, circulating Ab |
|
where do T cell precursors come from?
|
bone marrow
|
|
which surface antigen is specific for cytotoxic T cell?
|
CD8
|
|
which surface antigen is specific for helper T cell?
|
CD4
|
|
helper T cell is divided into these two cells?
|
Th1, Th2
|
|
Th1 cell function?
|
make IL2, IFN gamma and activate macrophages & CD8 T cell
inhibited by IL4 |
|
Th2 cell function?
|
make IL4, IL5 and help B cells make antibody (IgE >IgG); inhibited by IFN gamma
|
|
MHC is encoded by which gene?
|
heman leukocyte antigen (HLA) gene
|
|
types of MHC I genes?
|
HLA-A, B, C
|
|
MHC I is expressed on which cells?
|
almost all nucleated cells
|
|
fxn of MHC I?
|
antigen is loaded in RER.
mediates viral immunity pairs with beta2-microglobulin |
|
types of MHC II genes?
|
HLA-DR, DP, DQ
|
|
MHC II is expressed on?
|
only antigen presenting cells (APC)
|
|
fxn of MHC II?
|
antigen is loaded in an acidified endosome
|
|
fxn of B cell?
|
make Ab
IgG opsonize bacteria, virus |
|
type I hypersensitivity (allergy) is mediated by which Ig?
|
IgE
|
|
type II hypersensitivity(cytotoxic), and type III (immune complex) mediated by which Ig?
|
IgG
|
|
hyperacute organ rejection is mediated via what molecule?
|
antibody
|
|
fxn of T cells?
|
CD4 T cells help B cells make Ab and produce gamma interferon.. which activates macrophages
CD8 cells kill virus infected cells directly |
|
type IV (delayed type) hypersensitivity is mediated by?
|
T cells
|
|
acute and chronic organ rejection mediated by?
|
T cells
|
|
helper T cell's CD4 binds to what on APCs?
|
MHC II
|
|
cytotoxic T cell CD8 binds to ?
|
MHC I on virus infected cells
|
|
3 antigen presenting cells?
|
macrophage
B cell dendritic cell |
|
what's the role of CD3 complex?
|
cluster of polypeptide associated w/ a T cell receptor. important in signal transduction
|
|
what's a costimulatory signal?
|
CD28 on helper T cell binding to B7 on APC. needed to activate helper T cell along with MHC II - CD4 binding
|
|
how does cytotoxic t cell activation occur?
|
MHC I binding of TCR/CD8, and IL-2 from Th cell (helper cell) activate Tc cell to kill virus infected cell
|
|
what part of Ab bind to antigen?
|
variable light/heavy chain
|
|
Fc portion of Ab does what?
|
fixes complement (only IgM and IgG)
|
|
3 functions of Ab?
|
opsonization, neutralization, complement activation
|
|
Ab diversity generated by? (4 mechanism)
|
recombination: VJ (light) VDJ (heavy)
random combination of heavy and light chains somatic hypermutation addition of nucleotides to DNA during recombination by terminal deoxynucleotidyl transferase |
|
Mature B cell express which Ig on their surface?
|
IgM and IgD
|
|
what is isotype switching?
|
mediated by cytokines and CD40 ligand, they switch into plasma cells that secrete IgA, IgE or IgG
|
|
fxn of IgG?
|
main Ab in 2' response. fix complement, corsses placenta, opsonize bacteria, neutralize bacterial toxins and viruses
|
|
fnx of IgA?
|
prevents attachment of bacteria and viruses to mucous membranes. monomer or dimer. found in secretions
|
|
fxn of IgM?
|
produced in the 1' response to an antigen. fixes complement but does not cross the placenta. antigen receptor on surface of B cell. monomer on B cell or pentamer
|
|
fxn of IgD?
|
unclear. found on the surface of many B cells and in serum
|
|
fxn of IgE?
|
mediates immediate hypersensitivity (type I) by inducing the release of mediators from mast cells and basophils when exposed to allergen. mediates immunity to worms by activating eosinophils.
|
|
fxn of IL-1?
|
secreted by macrophage.
cause acute inflammation induce chemokine production to recreit leukocytes, activates endothelium to express adhesion moleculess |
|
fxn of IL-2?
|
secreted by Th cells.
stimulates growth of helper and cytotoxic T cells |
|
fxn of IL-3?
|
secreted by activated T cells
supports the growth and differentiation of bone marrow stem cells. has a fxn similar to GM-CSF |
|
fxn of IL-4?
|
secreted by Th2 cells promotes growth of B cells. enhances class switching to IgE and IgG
|
|
fxn of IL-5?
|
secreted by Th2 cells
promotes differentiation of B cells. Enhances class switching to IgA. stimulates production and activation of eosinophils |
|
fxn of IL-6?
|
secreted by Th cells and macrophages.
stimulates production of acute phase reactants and immunoglobulins. |
|
fxn of IL-8?
|
secreted by macrophages.
major chemotactic factor for neutrophils. |
|
fxn of IL-10?
|
secreted by regulatory T cells
inhibits actions of activated T cells |
|
fxn of IL-12?
|
secreted by B cells and macrophages.
activates NK and Th1 cells |
|
fxn of gamma interferon
|
secreted by Th1 cells.
stimulates macrophages. |
|
fxn of TNF?
|
secreted by macrophages
mediates septic shock. causes leukocyte recruitment, vascular leak. |
|
cell surface proteins on helper T cell?
|
CD4, TCR, CD3, CD28, CD40L
|
|
cell surface proteins on cytotoxic T cells?
|
CD8, TCR, CD3
|
|
cell surface proteins on B cells?
|
IgM, B7, CD19, CD20, CD21, CD40, MHC II
|
|
cell surface proteins on macrophages?
|
MHC II, B7, CD40, CD14. receptors for Fc and C3b
|
|
cell surface proteins on NK cells?
|
receptors for MHC I, CD16, CD56
|
|
all cells except mature red cells
|
MHC I
|
|
membrane attack complex defends against what type of bacteria?
|
gram negative bacteria
|
|
two path ways of activation of complement system?
|
classic pathway
alternative pathway |
|
complement classic pathway is activated via?
|
IgG or IgM
|
|
complement alternative pathway is activated via?
|
molecules on the surface of microbes (esp endotoxin)
|
|
two primary opsonins in bacterial defense?
|
C3b and IgG
|
|
which two molecules help prevent complement activation on self cells?
|
decay accelerating factor (DAF), and C1 esterase
|
|
complement that neutralize virus?
|
C1, C2, C3, C4
|
|
complement associated with anaphylaxis?
|
C3a, C5a
|
|
membrane attack complex (MAC) is composed of what complements?
fxn of MAC? |
C5b-9.
cytolysis |
|
this complement is a chemotactic factor for neutrophil
|
C5a
|
|
deficiency of C1 esterase inhibitor causes?
|
hereditary angioedema
|
|
deficiency of C3 leads to ?
|
severe, recurrent pyogenic sinus and respiratory tract infection
|
|
deficiency of C6-8 leads to?
|
neisseria bacteremia
|
|
deficiency of decay accelerating factor (DAF) leads to?
|
complement mediated lysis of RBCs and paroxysmal nocturnal hemoglobinuria (PNH)
|
|
role and mechanism of interferons?
|
place uninfected cells in an antiviral state.
interferons induce the production of a ribonuclease that inhibits viral protein synthesis by degrading viral mRNA (but not host mRNA) activates NK cells to kill virus infected cells |
|
alpha and beta interferon fxn?
|
inhibit viral protein synthesis
|
|
gamma interferon fxn?
|
increase MHC I and MHC II expression and antigen presentation in all cells
|
|
active immunity vs passive immunity?
|
active - induced after exposure to foreign antigens. slow onset, long lasting (memory)
passive - based on receiving preformed Ab from another host. rapid onset. short life span of Ab (half life = 3 weeks) |
|
preformed antibodies are given after exposure to what agents/viruses?
|
tetanus toxin, botulinum toxin, HBV or rabies
|
|
3 bacteria that has antigenic variation to invade host immune response?
|
salmonella (2 flagellar variant), borrelia (relapsing fever), neisseria gonorrhea (pilus protein)
|
|
virus that has antigenic variation?
|
influenza (antigenic shift and drift)
|
|
parasites that have antigenic variation?
|
trypanosome (programmed reacrrangement)
|
|
what is anergy?
|
self reactive T cells become non reactive without costimulatory molecule thus lack of response to foreign substance. B cells also become anergic, but tolerance is less complete than in T cells
|
|
type I hypersensitivity causes?
|
anaphylaxis, atopy
|
|
mechanism of type I hypersensitivity?
|
free antigen cross links IgE on presensitized mast cells and basophils triggering release of vasoactive amines (histamine). reaction develops rapidly after antigen exposure due to preformed antibody
|
|
mechanism of type II
(ab mediated) hypersensitivity? |
IgM or IgG bind to fixed antigen on enemy cell leading to lysis (by complement) or phagocytosis
|
|
mechanism of type III (immune complex mediated) hypersensitivity?
|
antigen-antibody complexes activate complement, which attracts neutrophils.
|
|
what is serum sickness?
|
immune complex disease(type III) in which Ab to the foreign proteins are produced (takes 5 days). Immune complexes form and are deposited in membranes where they fix complement (leads to tissue damage)
|
|
what is arthus reaction?
|
a local subacute Ab-mediated hypersensitivity (type III) reaction. intradermal infection of antigen induces Ab, which form antigen antibody complexes in the skin. characterized by edema, necrosis, and activation of complement
|
|
mechanism of type IV hypersensitivity?
|
delayed T cell mediated. sensitized T lymphocytes encounter antigen and then release lymphokines (leads to macrophage activation)
|
|
which type hypersensitivity causes these diseases?
hemolytic anemia idiopathic thrombocytopenic purpura erythroblastosis fetalis rheumatic fever goodpastures's bullous pemphigoid graves disease myasthenia gravis |
Type II
|
|
which type hypersensitivity causes these diseases?
T1DM MS guilllain Barre hashimoto GvHD PPD (test for TB) contact dermatitis |
type IV
|
|
which type hypersensitivity causes these diseases?
SLE rheumatoid arthritis polyarteris nodosum poststrep glomerulonephritis serum sickness arthus reaction hypersensitivity pneumonitis |
type III
|
|
which type hypersensitivity causes these diseases?
anaphylaxis allergic rhinitis |
type I
|
|
what disease is caused by decreased production of B cells?
|
bruton's agammaglobulinemia
|
|
characteristics of bruton's agammaglobilinemia?
|
X linked recessive. defect in tyrosine kinase. low levels of all classes of Ig. decrease in B cells. recurrent bacterial infections after 6 months of age. (when maternal Ab depletes) occurs in boys (X-linked)
|
|
what disease is caused by decreased production of T cells?
|
thymic aplasia (digeorge syndrome)
|
|
characteristics of digeorge?
|
thymus and parathyroids fail to develop owing to failure of development of 3rd and 4th pharyngeal pouches. presents w/ tetany due to hypocalcemia. recurrent viral and fungal infections. congenital defects of heart and great vessels. 22q11 deletion
|
|
what disease is caused by decreased production of B cells and T cells?
|
severe combined immunodeficiency (SCID)
|
|
characteristics of SCID?
|
defect in early stem cell differentiation. recurrent viral, bacterial, fungal and protozoal infection. multiple etiology (e.g. failure to synthesize MHC II, defective IL2 receptors or adenosine deaminase deficiency)
|
|
what disease is caused by decreased activation of T cells?
|
IL-12 receptor deficiency
|
|
characteristics of IL-12 receptor deficiency?
|
presents with disseminated mycobacterial infections due to decreased Th1 response
|
|
what disease is caused by decreased activation of B cells? (two)
|
hyper IgM syndrome
Wiskott-Aldrich syndome |
|
characteristics of hyper IgM syndrome
|
defect in CD40L on CD4 T helper cells leads to inability to class switch. presents early in life w/ severe pyogenic infections. high levels of IgM. very low IgG,A,E
|
|
characteristics of wiskott-aldrich syndrome?
|
X linked defect in ability to mount an IgM response to capsular polysaccharides of bacteria. elevated IgA, normal IgE and low IgM.
Triad - recurrent pyogenic infection, thrombocytopenic purpura, eczema |
|
what disease is caused by decreased activation of macrophages?
|
job's syndrome
|
|
characteristics of job's syndrome?
|
failure fo IFN gamma production by helper T cells. PMN fail to respond to chemotactic stimuli.
presents with - coarse facies, cold (noninflamed) staph abscess, retained 1' teech, increased IgE, dermatologic problems |
|
what disease is caused by phagocytic cell deficiency? (3)
|
leukocyte adhesion deficiency syndrome (type 1)
chediak-higashi disease chronic granulomatous disease |
|
characteristics of leukocyte adhesion deficiency?
|
defect in LFA-1 integrin proteins on phagocytes. presents early w/ recurrent bacterial infections, pus formation, and delayed separation of umbilicus
|
|
characteristics of chediak higashi disease?
|
autosomal recessive. defect in microtubular function and lysosomal emptying of phagocytic cells. presents w/ recurrent pyogenic infection by staph and strep. partial albinism, peripheral neuropathy
|
|
a patient presents w/ marked susceptibility to opportunistic infections, esp S aureus, e coli, aspergillus. Dx confirmed w/ negative nitroblue tetrazolium dye reduction test
what disease? |
chronic granulomatous disease
|
|
chronic granulomatous disease mechanism?
|
defect in phagocytosis of neutrophils owing to lack of NDAPH oxidase activity or similar enzymes
|
|
patient presents with skin and mucous membrane candida infection, due to idiopathic dysfunction of T cells. what disease?
|
chronic mucocutaneous candidiasis.
T cell dysfunction specifically against candida albicans |
|
pt presents w/ sinus and lung infection. milk allergy and diarrhea present. what disease?
|
selective immunoglobulin deficiency (idiopathic dysfunction of B cells)
possibly due to a defect in isotype switching. IgA def most common |
|
pt presents w/ cerebellar problems and spider angioma.
what disease? |
ataxia-telangiectasia (idiopathic dysfunction of B cells)
|
|
mechanism of ataxia telangiectasia
|
defect in DNA repair enzymes w/ associated IgA deficiency
|
|
a young pt in 20s has decreased plasma cell but normal # of circulating B cells. decrease in Igs.
what disease? |
common variable immunodeficiency (idiopathic dysfunction of B cells)
|
|
what disease?
antinuclear antibody (ANA) |
SLE
|
|
what disease?
anti-dsDNA, anti-smith |
specific for SLE
|
|
what disease?
antihistone |
drug induced lupus
|
|
what disease?
anti IgG |
rheumatoid arthritis (rheumatoid factor)
|
|
what disease?
anticentromere |
scleroderma (CREST)
|
|
what disease?
anti Scl70 |
scleroderma (diffuse)
|
|
what disease?
antimitochondrial |
1' biliary cirrhosis
|
|
what disease?
antigliadin |
celiac disease
|
|
what disease?
anti basement membrane |
goodpasture's
|
|
what disease?
anti-epithelial cell |
pemphigus vulgaris
|
|
what disease?
antimicrosomal, antithyroglobulin |
hashimoto's thyroiditis
|
|
what disease?
anti Jo-1 |
polymyositis, dermatomyositis
|
|
what disease?
anti SS-A (anti Ro) |
Sjogren's syndrome
|
|
what disease?
anti SS-B(anti Ra) |
sjogren's syndrome
|
|
what disease?
anti U1 RNP |
mixed connective tissue disease
|
|
what disease?
antiglutamate decarboxylase |
T1DM
|
|
what disease?
anti smooth muscle |
autoimmune hepatitis
|
|
what disease?
c-ANCA |
wegener's granulomatosis
|
|
what disease?
p-ANCA |
other vasculitides (than wegener, SLE, goodpasture)
|
|
HLA-B27 associated with what diseases?
|
prosirasis, ankylosing spondylitis, IBD, reiter's syndrome
|
|
HLA-B8 associated with what diseases?
|
graves disease, celiac sprue
|
|
HLA-DR2 associated with what diseases?
|
multiple sclerosis, hay fever, SLE, goodpastures
|
|
HLA-DR3 associated with what diseases?
|
T1DM
|
|
HLA-DR4 associated with what diseases?
|
rheumatoid arthritis, T1DM
|
|
HLA-DR5 associated with what diseases?
|
pernicious anemia -> B12 deficiency, hashimoto's thyroiditis
|
|
HLA-DR7 associated with what diseases?
|
steroid responsive nephrotic syndrome
|
|
what is syngeneic graft?
|
from identical twin or clone
|
|
mechanism, clinical use and toxicity of cyclosporine?
|
mech - bind to cyclophilin. complex blocks the differentiation and activation of T cells by inhibiting calcineurin, thus preventing the production of IL2 and its receptor
clinical - suppresses organ rejection after transplant. selected autoimmune disorders toxicity - predisposition to viral infection and lymphoma. nephrotoxic(preventable w/ mannitol diuresis) |
|
mechanism, clinical use and toxicity of tacrolimus (FK506)?
|
mech - similar to cyclosporine; binds to FK binding protein, inhibiting secretion of IL2 and other cytokines
clinical use - potent immunosuppressive used in organ transplant recipients toxicity - nephrotoxicity, peripheral neuropathym HTN, pleural effusion, hyperglycemia |
|
mechanism, clinical use and toxicity of azathioprine?
|
mech - antimetabolite precursor of 6-mercaptopurine that interferes w/ metabolism and synthesis of nucleic acids. toxic to proliferating lymphocytes
clinical use - kidney transplant, autoimmune disorders toxicity - bone marrow suppression. active metabolite mercaptopurine is metabolized by xanthine oxidase; thus toxic effect increase by allopurinol |
|
mechanism, clinical use and toxicity of muromonab-CD3 (OKT3)
|
mech - monoclonal ab binding to CD3 on T cell surface. blocks cellular interaction w/ CD3 responsible for T cell signal transduction
clinical - immunosuppression after kidney transplant toxicity - cytokine release syndrome, hypersensitivity reaction |
|
mechanism, clinical use and toxicity of sirolimus (rapamycin)
|
mech - binds to mTOR. inhibit T cell proliferation in response to IL-2
clinical use - immunosuppression after kidney transplantation in combination w/ cyclosporine and corticosteroids toxicity - hyperlipidemia, thrombocytopenia, leukopenia |
|
mechanism of mycophenolate mofetil
|
inhibits de novo guanine synthesis and blocks lymphocyte production
|
|
mechanism of daclizumab
|
monoclonal ab w/ high affinity for IL2 receptor on activated T cells
|
|
clinical use of aldesleukin (IL-2)
|
renal cell carcinoma,metastatic melanoma
|
|
clinical use of erythropoietin (epoetin)
|
anemia (esp in renal failure)
|
|
clinical use of filgrastim (G-CSF)
|
recovery of bone marrow
|
|
clinical use of sargramostim (GM-CSF)
|
recovery of bone marrow
|
|
clinical use of alpha interferon
|
hep B, C, kaposi's sarcoma, leukemia, malignant melanoma
|
|
clinical use of beta interferon
|
multiple sclerosis
|
|
clinical use of gamma interferon
|
chronic granulomatous disease
|
|
clinical use of oprelvekin (IL-11)
|
thrombocytopenia
|
|
clinical use of thrombopoietin
|
thrombocytopenia
|
|
what is hyperacute rejection?
|
Ab mediated due to presence of preformed antidonor Ab in the transplant recipient. occurs within minutes after transplant
|
|
what is acute rejection?
|
cell mediated due to cytotoxic T lymphocytes reacting against foreign MHCs. occurs weeks after transplant. reversible w/ cyclosporine/OKT3
|
|
what is chronic rejection?
|
Ab mediated vascular damage (fibrinoid necrosis); occurs months to yrs after transplantation. irreversible
|
|
what is GvH disease
|
grafted immunocompetent T cells proliferate in the irradiated immunocompromised host and rejects cells w/ foreign proteins resulting in severe organ dysfunction.
Sx - maculopapular rash, jaundice, hepatosplenomegaly and diarrhea |